Severance Hospital, Yonsei University Health System ( Site 5903)

Seoul 03722

1 studies enrolling now · 1 studies all time

What they study most

Bladder Cancer

Studies at this site

• KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04) — Recruiting now